من السبت الى الخميس (8:00AM-2:00PM)
تواصل معنا : 07845092037 - 07748083710







  • م.م اسيل جليل ابراهيم خلف
  • Assist. Lecturer . Aseel Jalil Ibrahim
  • تدريسي : طب الاسنان
  • Teaching : Collage of Dentistry
  • ماجستير في طب الاسنان/ امراض وجراحة ماحول الاسنان
  • M.Sc.in periodontics
  • dr.aseel@bauc14.edu.iq
  • aseeljaleel68@gmail.com
  • السيرة الذاتية
  • Google Scholar
  • FaceBook

    • نشاطات التدريسي

    البحوث المنشورة

    المؤلفات

    المقررات المكلف بها

    المحاضرات

    مشاريع التخرج

    المقالات داخل المجلة

    المقررات المكلف بها

    المقررات المكلف بها - 2
    القسم المرحلة الفصل رمز المقرر الوحدات توصيف المقرر
    طب الاسنان المرحلة الرابعة سنوي 5 امراض ماحول الاسنان Periodontics
    طب الاسنان المرحلة الخامسة سنوي 5 امراض ماحول الاسنان Periodontics

    المحاضرات الالكترونية

    المحاضرات الالكترونية - 50
    العام المقرر القسم المرحلة المحاضرة
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة TRAUMA FROM OCCLUSI
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة toll-like-receptors-in-periodontology
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة Sonic and ultrasonic instrumentation and irrigation
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة Smoking and Periodontal diseases
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة Radiographic aids in periodontology
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة PERIODONTICS WITH OTHER ASPECT OF DENTISTRY
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة Periodontal Surgery
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة Periodontal regeneration
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة Perio plastic Surgery
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة peri-implant anatomy
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة peri implant mucosa
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة PATHOGENESIS OF PERIODONTAL DISEASE
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة medically compromised patient2
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة medically compromised patient
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة local-drug-delivery
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة lasers-and-its-application-in-periodontics
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة laser
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة implant
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة immunity part 2( adaptive)
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة immunity part 1( innate)
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة HOST-PARASITE INTERACTIONS
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة healing
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة HALITOSIS
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة GCF
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة Furcation involvement
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة EXAMINATION AND DIAGNOSIS OF PATIENT WITH PERIODONTAL DISEASE
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة EPIDEMIOLOGY
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة Dentine Hypersensitivity
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة Cementum
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة bone-loss-and-patterns-of-bone-destruction-55680561
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة Bone loss and patterns of bone destruction
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الخامسة advanced periodontal diagnostic tech
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الرابعة Phase I Therapy
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الرابعة Treatment planning for patients With Periodontal Diseases
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الرابعة pocket
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الرابعة Phase II Therapy surgical Therapy
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الرابعة Phase I Therapy
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الرابعة Periodontal ligament
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الرابعة Periodontal instruments
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الرابعة Periodontal indices
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الرابعة Mucogingival surgery
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الرابعة Gingival and periodontal pocket
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الرابعة EXAMINATION AND DIAGNOSIS OF PATIENT WITH PERIODONTAL DISEASE
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الرابعة Etiology and Risk factors for periodontal diseases
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الرابعة dental stain
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الرابعة DENTAL PLAQUE BIOFILM
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الرابعة CLASSIFICATION OF PERIODONTAL DISEASE
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الرابعة CLASSIFICATION OF PERIODONTAL DISEASE
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الرابعة Anatomy of Periodontium
    2024-2025 امراض ماحول الاسنان Periodontics طب الاسنان المرحلة الرابعة alveolar process

    البحوث

    2017 : Research Journal of Pharmaceutical, Biological and Chemical Sciences
    Osteoporosis and periodontal disease stand for a major health problem principally in aged women with complex as well as recognized bidirectional association. Postmenopausal osteoporosis also known as type I osteoporosis typifies a common illness in womanly patients by the beginning of menopause, owing to estrogen reduction after menopause. Alendronate is a first line drug for treatment of postmenopausal osteoporosis and it is a powerful inhibitor of osteoclast action that diminish bone resorption moreover, it was suggested of having osteo stimulative property in vivo and in vitro as revealed through increase in bone matrix formation. Thus medical management of postmenopausal osteoporosis women with alendronate may well have valuable outcome on periodontal health condition. 1.To estimate and compare the periodontal health status of the study and control groups. 2. To assess the effect of alendronate treatment on clinical periodontal parameters (plaque index(PLI),gingival index(GI),bleeding on probing(BOP),probing pocket depth(PPD),and clinical attachment level(CAL) in postmenopausal women with osteoporosis.3.To correlate between Alendronate intake duration and clinical periodontal parameters. 90 participants, females only were conscripted in this study with age ranged from (55-65) years old, were divided into three groups, (30 subjects each):first control group systemically healthy with healthy periodontium, second group postmenopausal women with osteoporosis under alendronate treatment for (3-6)months(Alendronate group) ,third group postmenopausal women with osteoporosis only without alendronate treatment(Osteoporosis group), the last two groups were sub divided in to two sub group each one consist of 15 gingivitis and 15 periodontitis . Periodontal health status was determined by clinical periodontal examination of plaque index (PLI), gingival index (GI), bleeding on probing (BOP), probing pocket depth (PPD) and clinical attachment level (CAL). Postmenopausal women with osteoporosis demonstrated the highest median values of all clinical periodontal parameters followed by Alendronate group, then the control group with healthy periodontium and systemically healthy ( except for plaque index with higher value in Alendronate group). total correlation between drug intake duration and clinical periodontal parameters were weak negative non significant with ( BOP, PPD,CAL) except for( PLI , GI) there were strong positive highly significant and weak positive highly significant correlation respectively between them. Patients with osteoporosis had greater periodontal tissue destruction comparing with patients with alendronate treatment with less periodontal tissue destruction. Additionally alendronate treatment may have beneficial outcome on periodontal health status in postmenopausal women with osteoporosis and periodontal disease

    2018 Journal of Baghdad College of Dentistry
    Background: All diseases concerning bone destruction such as osteoporosis and periodontal diseases share common pattern in which the osteoclast cells are absolutely responsible for bone resorption that occurred when osteoclast activity exceeds osteoblast activity. Osteoprotegrin (OPG) considered as novel soluble decoy receptor known as “bone protector” since it prevents extreme bone resorption through inhibition of differentiation and activity of osteoclast by competing for binding site. It binds to receptor activator of nuclear factor kappa-B ligand (RANKL) and prevent its interaction with receptor activator of nuclear factor kappa-B (RANK), thus inhibits osteoclast formation. TNF-α is a pro-inflammatory cytokines having a broad range of important roles in regulation of immune system and bone resorption through the stimulation of osteoclastogenesis. Alendronate (ALN) diminishes the expression of osteoclast activating factors and cytokines such as RANKL and enhances the production of decoy receptor osteoprotegerin in osteoblast cells. Moreover, it decreases the production of proinflammatory cytokines such as TNF-α by macrophage, stimulates apoptosis of monocyte-macrophage cell lines derivative and reduces inflammatory response. Aims of the Study: 1. To assess the effect of alendronate treatment on salivary levels of osteoprotegrin and TNF-α in postmenopausal women with osteoporosis and periodontal disease 2. To find any possible correlation between salivary levels of osteoprotegrin and TNF-α in control and study groups. Materials and Methods: Total sample of 90 female subjects (55-65 years) were divided into 3 groups, (30 subjects in each group): first control group involved systemically healthy subjects with healthy periodontium, second group involved postmenopausal women with osteoporosis under alendronate treatment for(3-6)months (alendronate group), third group involved postmenopausal women with osteoporosis without alendronate treatment(osteoporosis group). The last two groups were sub- divided in- to two sub –groups (15 subjects in each sub-group) of gingivitis and periodontitis subjects respectively. Salivary samples were collected from all subjects and salivary levels of osteoprotegrin and TNF- α were determined by enzyme –linked immune sorbent assay (ELISA). Results: Highest median value of salivary (OPG) was found in alendronate group followed by control group while the lowest value was found in osteoporosis group. Highest median value of TNF- α was found in osteoporosis group followed by control group and alendronate group respectively with highly significant differences between them. Spearman correlation between salivary levels of TNF-α and OPG showed non- significant correlation at all subgroups. Conclusion: Subjects with osteoporosis in this study had greater levels of TNF-α and decrease in the level of OPG comparing with patients under alendronate treatment. Alendronate treatment for women with osteoporosis and periodontal disease may have beneficial outcome.

    2023 Dentistry 3000
    BACKGROUND: One hundred and twenty specimens were collected from pa,ents with Peri-implan,,s in the period from August 2022 un,l September 2022 from Baqub specialized dental center, in the province of Diyala. The goal of this work was to es,mate the frequency of Staphylococcus aureus and their ability to produce biofilms associated with Peri-implan,,s. Also, we aimed to assess the an,-biofilm property of Ciprofloxacin and Amoxicillin/clavulanic acid on Staphylococcus aureus. The result showed growth of Staphylococcus aureus in twenty isolates (16.6%), and 95% of the Staphylococcus aureus isolates had the ability to produce biofilms. The results indicate that the minimum inhibitory concentra,on (MIC) of Ciprofloxacin for Staphylococcus aureus was 32 to 512 μg/ml with the sub-MIC 16 to 256 μg/ml. The MIC for Amoxicillin/clavulanic was 8 to 512 μg/ml, and the sub-MIC 4 to 256) μg/ml. Ciprofloxacin and Amoxicillin/clavulanic acid had the ability to decrease biofilm forma,on and Amoxicillin/clavulanic acid was more effec,ve than Ciprofloxacin.

    2023 The Egyptian Journal of Hospital Medicine
    Background: Application and development of oral health education (OHE) program is critical to recognize and to improve the risk of oral and dental health factors among adolescents. Aim: The purpose of the study was to evaluate the developments in the adolescents' oral health behavior and skills, in comparison with the pupils' situation before the teachers' training. Materials and Methods: Seven schools in the city of Diyala-Baquba participated in a randomized controlled experiment for this research. Eighty males and females aged 12 with good general health participated in this study over the course of 16weeks to evaluate the effects of a school-based OHE program on their oral hygiene, gum health, and halitosis. From the selected schools, one subjected to the intervention of OHE program and one of them was a control. A questionnaire was used to measure both general and oral health. In order to better prepare the teachers, a course lasting three days planned. To evaluate levels of oral hygiene, we used plaque indices, gingival indices, and halitosis scores to evaluate their breath. Results: Results showed that intervention school showed statistically significant improvements in student oral health indicators such plaque, gingivitis, and halitosis scores. Comparing teacher-led group to the controls and the baseline assessment, the former was found significantly lower scores for the plaque index, gingival index, and halitosis. There were significant differences discovered statistically (P< 0.01). Conclusions: School's children in the teacher-led OHE group showed significant improvements in their oral health, hygiene, gingival health, and oral malodor.




    En